Labcorp (NYSE:LH – Get Free Report) and INVO Fertility (NASDAQ:IVF – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.
Risk & Volatility
Labcorp has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.39, suggesting that its share price is 139% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current recommendations for Labcorp and INVO Fertility, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Labcorp | 0 | 3 | 9 | 0 | 2.75 |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
Earnings and Valuation
This table compares Labcorp and INVO Fertility”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Labcorp | $14.35 billion | 1.74 | $876.50 million | $12.09 | 25.52 |
| INVO Fertility | $6.84 million | 0.30 | -$25.13 million | ($33.83) | -0.02 |
Labcorp has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Labcorp and INVO Fertility’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Labcorp | 6.99% | 16.74% | 7.81% |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
Insider and Institutional Ownership
95.9% of Labcorp shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 0.4% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Labcorp beats INVO Fertility on 12 of the 15 factors compared between the two stocks.
About Labcorp
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for Labcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp and related companies with MarketBeat.com's FREE daily email newsletter.
